CCLD
CareCloud Inc

12,454
Mkt Cap
$126.83M
Volume
5,310.00
52W High
$4.75
52W Low
$1.14
PE Ratio
72.24
CCLD Fundamentals
Price
$2.96
Prev Close
$2.94
Open
$2.94
50D MA
$3.09
Beta
1.28
Avg. Volume
284,099.14
EPS (Annual)
-$0.2762
P/B
2.16
Rev/Employee
$30,366.30
News
all
press releases
CareCloud (NASDAQ:CCLD) Stock Price Down 0.3% - Here's What Happened
CareCloud (NASDAQ:CCLD) Stock Price Down 0.3% - Time to Sell...
MarketBeat·10d ago
News Placeholder
More News
News Placeholder
CapsoVision Submits FDA 510(k) for AI-Assisted Module in CapsoCam Plus
CV seeks FDA clearance to add AI-based reading to CapsoCam Plus to boost diagnostic accuracy and streamline reviews.
Zacks·11d ago
News Placeholder
KRMD Submits 510(k) to Use FreedomEDGE System With Oncology Biologic
KORU Medical filed a 510(k) to use FreedomEDGE for subcutaneous PHESGO delivery, expanding into oncology and simplifying breast cancer care.
Zacks·13d ago
News Placeholder
Should Value Investors Buy CareCloud (CCLD) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks·18d ago
News Placeholder
FLGT to Acquire Bako & StrataDx Assets to Expand Pathology Platform
Fulgent is set to buy Bako Diagnostics assets and StrataDx for $55.5M, expanding into anatomic pathology and dermatopathology to scale lab services.
Zacks·21d ago
News Placeholder
Here's Why You Should Retain INSP Stock in Your Portfolio Now
INSP's Inspire V gains traction with strong clinical data, improving reimbursement visibility and cost control, even as inventory and GLP-1 headwinds persist.
Zacks·22d ago
News Placeholder
Revvity Advances AI-Driven Scientific Discovery With Signals Xynthetica
RVTY unveils Signals Xynthetica, an AI-augmented design platform that links predictive models with real lab data to speed discovery.
Zacks·25d ago
News Placeholder
3 MedTech Innovators Shaping Healthcare in 2026: AVAH, INGN & CCLD
AVAH, INGN & CCLD show how home care, portable oxygen tech and cloud healthcare IT are reshaping care delivery and efficiency into 2026.
Zacks·25d ago
News Placeholder
Here's Why You Should Retain CLOV Stock in Your Portfolio Now
Clover Health shows strong membership growth, rising revenues and sustained EBITDA gains from Clover Assistant, though near-term margin pressure remains a risk.
Zacks·26d ago
News Placeholder
Should Value Investors Buy CareCloud (CCLD) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks·1mo ago
<
1
2
...
>

Latest CCLD News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.